Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
34896 participants
OBSERVATIONAL
2021-02-09
2022-02-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Increasing Patient Engagement in the Annual Well Visits Program
NCT03462394
UCLA Health Patient Cardiology Care Gaps
NCT06277323
Comparing the Effectiveness of Different Appointment Reminder Methods
NCT06767423
Improving Advance Care Planning by Preparing Diverse Seniors for Decision Making
NCT01990235
Advance Care Planning Notifications in General Inpatient Medicine
NCT04756583
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Call center phone call
Participants randomized to this arm will receive a phone call from the call center reminding them to schedule their appointments.
Participant outreach
Participants in the experimental arms will receive a call center phone call or MyChart message to remind them to schedule their appointments.
No call center phone call
Participants randomized to this arm will not receive a phone call from the call center reminding them to schedule their appointments.
No interventions assigned to this group
MyChart message
Participants randomized to this arm will receive an automated MyChart message reminding them to schedule their appointments.
Participant outreach
Participants in the experimental arms will receive a call center phone call or MyChart message to remind them to schedule their appointments.
No MyChart message
Participants randomized to this arm will not receive an automated MyChart message reminding them to schedule their appointments.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Participant outreach
Participants in the experimental arms will receive a call center phone call or MyChart message to remind them to schedule their appointments.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
3 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leora Horwitz, MD
Role: PRINCIPAL_INVESTIGATOR
NYU Langone Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NYU Langone Health
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QI-CIN Gaps Predictive Model
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.